Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

IMPACT HEALTHCARE, PLLC

NPI: 1639656986 · SPRINGFIELD, TN 37172 · Internal Medicine Physician · NPI assigned 07/19/2018

$0.00
Total Medicaid Paid
657
Total Claims
479
Beneficiaries
6
Codes Billed
2022-08
First Month
2024-01
Last Month

Provider Details

Authorized OfficialTURNER, ANDREW (PRESIDENT)
NPI Enumeration Date07/19/2018

Related Entities

Other providers sharing the same authorized official: TURNER, ANDREW

ProviderCityStateTotal Paid
IMPACT HEALTHCARE, PLLC JACKSON TN $10.11M
PATHWAY HEALTHCARE- MISSISSIPPI LLC VICKSBURG MS $2.61M
IMPACT BEHAVIORAL COUNSELING LLC DALLAS TX $255K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2022 289 $0.00
2023 337 $0.00
2024 31 $0.00

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 189 160 $0.00
G2087 Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month 84 83 $0.00
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 31 25 $0.00
99484 12 12 $0.00
80305 176 144 $0.00
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 165 55 $0.00